Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Vöcklabruck
Clinical trial register · Austria

Clinical Trials in Vöcklabruck, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Austria and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1586 matching records held by the registry are in this view. Synced 14 Nov 2026, 03:18 UTC
1586
Studies in scope
all four open statuses
855
Recruiting now
open to new participants
341
Lead sponsors
across recruiting studies
Top sites
Vienna 1013 Graz 514 Linz 434 Innsbruck 396 Salzburg 292
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Trials with a site in Vöcklabruck

7 of 1586 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Austria
Start
Not yet open
Digital Application for Stroke Health
NCT07511868Haemorrhagic Stroke, Ischaemic Stroke, Transient Ischemic Attack (TIA)
VASCage GmbH
Not applicable
500
Tulln, Vienna, Graz, Innsbruck, Linz, Steyr, Vöcklabruck
2026-04-01
By invitation
Implementation of Advanced Practice Nurses for Specific Patient Groups
NCT07693023Evaluate Structures, Processes, and Experiences Related to the Implementation of APN Roles
Paracelsus Medical University
Observational
125
Vöcklabruck
2026-03-01
Active, closed
Novo Nordisk A/S
Phase 3
412
Linz, Dornbirn, Sankt Pölten, Vöcklabruck
2022-08-10
Active, closed
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
NCT04595565HER2-negative Breast Cancer, Triple Negative Breast Cancer
GBG Forschungs GmbH
Phase 3
1,332
Graz, Innsbruck, Linz, Salzburg, Sankt Pölten, Vienna, Vöcklabruck, Wels
2020-10-28
Active, closed
Novo Nordisk A/S
Phase 2
62
Linz, Graz, Salzburg, Sankt Pölten, Vöcklabruck
2019-07-04
Active, closed
Ipsen
Observational
224
Leoben, Linz, Salzburg, Vöcklabruck, Wels
2018-09-24
Rows per page Showing 1–7 of 7
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Austrian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 17 November 2026. https://priyalifescience.com/clinical-trials-austria/city/v-cklabruck

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Austria and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,586 studies in total at the last sync on 14 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 7 of those studies with a site in Vöcklabruck.

How many clinical trials are recruiting in Vöcklabruck?

1 of the 7 studies on this page are recruiting new participants as of the 14 Nov 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 4 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Vöcklabruck), 7 studies
PhaseStudiesRecruitingShare
Observational3142.9%
Phase 32028.6%
Not applicable1014.3%
Phase 21014.3%

Most active sponsors

Lead sponsors with the most studies (Vöcklabruck)
Lead sponsorStudiesRecruiting
Novo Nordisk A/S20
Esteve Pharmaceuticals, S.A.11
GBG Forschungs GmbH10
Ipsen10
Paracelsus Medical University10
VASCage GmbH10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.